Enorama Pharma AB (publ) (ERMA.ST)
STO
Healthcare
Medical - Pharmaceuticals
$0.67
▼ -4.57%
Market Cap
$49.8M
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
1.80
52-Wk Range
0.211-3
CEO
Bengt Jönsson
Country
SE
Currency
SEK
Enorama Pharma AB (publ) operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Stockholm, AB, SE. The stock last traded at $0.67, down 4.57% on the session, giving a market capitalisation of $49.8M. Its beta of 1.80 implies it has historically moved more than the broad market.
Company profile
Exchange
Stockholm Stock Exchange
Employees
4
IPO date
2016-06-10
Headquarters
Stockholm, AB, SE
About Enorama Pharma AB (publ)
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.
Comparable companies
Enorama Pharma AB (publ) is most often compared with the following Healthcare names:
More research on ERMA.ST
Open full interactive analysis & DCF →